Skip to main content
Premium Trial:

Request an Annual Quote

J&J to Use Gene Network Sciences Modeling Platform for Oncology Research

NEW YORK, March 7 (GenomeWeb News) - Gene Network Sciences said today that Johnson & Johnson Pharmaceutical Research & Development will use its computer-modeling technology as part of its cancer research efforts.


GNS said that J&JPRD will use its pathway inference technology and computer models to help identify pathways associated with the mechanism of action, biomarkers, and tumor specificity of a pre-clinical oncology compound.


Financial terms of the agreement were not disclosed.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.